<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03843580</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A00112-55</org_study_id>
    <nct_id>NCT03843580</nct_id>
  </id_info>
  <brief_title>Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo)</brief_title>
  <acronym>optilaryngo</acronym>
  <official_title>Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Francois Baclesse</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Suspension laryngoscopy is realised during apnea. In effect, surgeons are in the mouth of the
      patient and we can't have access at the aiways.

      So investigators like to use a Transnasal Humidified Rapid-Insufflation Ventilatory Exchange
      (THRIVE) to increase time of apnea and decrease the impact of oxygen desaturation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2019</start_date>
  <completion_date type="Anticipated">February 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>desaturation defined as the number of patient who presented at least one desaturation during suspension laryngoscopy</measure>
    <time_frame>Two hours</time_frame>
    <description>the number of patient who presented at least one desaturation during suspension laryngoscopy. An oxygen desaturation define like SpO2&lt;96%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hypoxemia (decrease the number of Hypoxemia event define like SpO2&lt;90%)</measure>
    <time_frame>2 hours</time_frame>
    <description>Decrease the number of Hypoxemia event define like SpO2&lt;90%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effect</measure>
    <time_frame>2 hours</time_frame>
    <description>decrease the number of side effects</description>
  </secondary_outcome>
  <other_outcome>
    <measure>time of apnea</measure>
    <time_frame>2 hours</time_frame>
    <description>increase time of apnea with THRIVE</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Apnea, Postanesthetic</condition>
  <condition>Desaturation of Blood</condition>
  <condition>Apnea</condition>
  <condition>Anesthesia</condition>
  <condition>Larynx Disease</condition>
  <condition>Pharynx; Anomaly</condition>
  <arm_group>
    <arm_group_label>Standard Allocation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>apnea without oxygenation like usual traitement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oxygenation optiflow</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>optiflow oxygenation during apnea</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>optiflow</intervention_name>
    <description>we use Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (thrive-optiflow) during general anesthesia for suspension laryngoscopy</description>
    <arm_group_label>oxygenation optiflow</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  suspension laryngoscopy

        Exclusion Criteria:

          -  THRIVE contraindication:

          -  epistaxis

          -  undrained pneumothorax

          -  Recent gastroesophageal surgery (1months)

          -  Skull Fractures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc Hanouz</last_name>
    <role>Study Chair</role>
    <affiliation>Caen UH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eleonore Mulac-Vauclair</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Francois Baclesse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre-Emmanuel Marsan</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Caen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kamga Herve</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Caen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Boutros Mariam</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Marsan</last_name>
    <phone>0609498024</phone>
    <email>pierreemmanuel.marsan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mariam Boutros</last_name>
    <email>mariamboutros84@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CaenUH</name>
      <address>
        <city>Caen</city>
        <state>Normandie</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierreemmanuel Marsan</last_name>
      <phone>0609498024</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Fran√ßois Baclesse</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleonore Mulac</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 13, 2019</study_first_submitted>
  <study_first_submitted_qc>February 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2019</study_first_posted>
  <last_update_submitted>April 24, 2019</last_update_submitted>
  <last_update_submitted_qc>April 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Time of apnea</keyword>
  <keyword>Optiflow</keyword>
  <keyword>Thrive</keyword>
  <keyword>Apnea oxygenation</keyword>
  <keyword>Suspension laryngoscopy</keyword>
  <keyword>General Anesthesia</keyword>
  <keyword>Oxygenation apnea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Laryngeal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

